In 2024, S&P 500 had an impressive profit of about 25%, which significantly estimated its average annual growth rate over the past few decades, which is much closer to 10%. After another strong year, for a wider market, investors may have entered in 2025 with huge reliable that this impulse would continue. Fortunately, although there is no guarantee that the market will continue the rally in the future, there are a number of exchange funds (ETFs) that have experienced mass rises in the first weeks of the year. As of February 5, 2025, in just a month in the new year, each of the funds below grew at least about 14% (and sometimes a little more) over the years, while S&P 500 rose straight more than 3% for the same period.
STKD Bitcoin & Gold ETF: Double focus for risk balance
STKD Bitcoin & Gold ETF today
STKD Bitcoin & Gold ETF
- 52-week range
- $ 19.80
▼
$ 31.85
- Assets under the control
- 27.07 million dollars
Launched in October 2024, Stkd Bitcoin & Gold ETF NYSARCA: BTGD It is a new fund on our list. BTGD is an example of the so -called complex ETF, a fund that focuses simultaneously on two assets with a common topic. The BTGD goal is to ensure a double exposure of both bitcoin and gold – the supplier of the fund assumes that each invested dollar is designed to ensure the dollar of bitcoin costs and the dollar on the influence of gold.
An interesting aspect of BTGD is that it is aimed at achieving this double focus, without investing directly in any of the assets themselves. Thus, BTGD has no physical gold or ingots, and at the same time it does not invest directly in any digital assets. Rather, BTGD invests in futures and exchange products both in gold and in bitcoins. Investors can be involved in balance, which provides each of these assets compared to others; Bitcoin is very unstable and remains in a muddy regulatory space, while gold is a metal with a safe refuge and a historical repository.
Thanks to active control, BTGD carries a fairly high fee of 1.0%. Nevertheless, investors who see that the fund has returned 13.6% since the beginning of the year, a little over a month in 2025, may want to spend a little more for a fee.
Simplifying opportunities for promoting ETF: High fee for a unique examination
Simplifying Opel ETF capabilities today
Simplify Opel ETF capabilities
- 52-week range
- $ 14.82
▼
$ 27.52
- Dividend yield
- 11.96%
- Assets under the control
- 80.43 million dollars
With a cost ratio of 2.54%, simplifying the possibilities for promoting ETF NYSEARCH: Suri It comes at a steep price. This actively controlled fund had a profit of 18.1% from the beginning of 2025 to February 6, it is possible that, perhaps, providing a high fee.
Suri focuses on biotechnology, pharmaceuticals, healthcare technologies and life science firms that “investors overlook”. The Fund is aimed at using the examination of the subsidder to identify promising healthcare sectors, which investors may not see investors without deep knowledge in the field.
The fund has a relatively narrow basket of 22 names on the date above.
Renaissance nuclear index of ETF: Capitalization of pure energy pushes
The range of the eTF nuclear renaissance index today
The range of nuclear renaissance index ETF
- 52-week range
- $ 25.43
▼
$ 52.10
- Assets under the control
- 226.07 million dollars
The range of the nuclear era of the Renaissance ETF NYSEARCH: NUKZ Target companies involved in advanced reactors, utilities, construction and services and fuel segments of the atomic energy industry.
With a significant increase in demand for net energy, the expected will continue in the future, nuclear sources are gaining popularity.
Nukz has the lowest cost coefficient in our list, by 0.85%, and profitability from the beginning of more than 21% as of February 6. Investors should note that it is rightly concentrated on several names and three best positions of about a third of all assets.
Advisorshares Psychedelics ETF: Medical Potential for Mental Health
Advisorshares psychedelics etf today
Advisorshares Psychedelics ETF
- 52-week range
- $ 7.14
▼
$ 17.00
- Dividend yield
- 0.34%
- Assets under the control
- 10.19 million dollars
An unexpected best performer at the beginning of 2025 is ETF Advisorshares ETF NYSEARCA: PSILwhich returned the colossal 37.2% this year. The Fund invests in biotechnological, pharmaceutical and life companies that have significant income or other attention on the development of psychedelic drugs with potential applications in the psychiatric industry.
Psil is an actively controlled fund, but has a reasonable cost coefficient of 0.99%.
A unique Psil focus means that it invests in some unusual names in the niche part of the biotechnological and pharmaceutical industry. Thus, this fund can offer investors the exposure of companies that are unlikely to be displayed in any other ETF portfolios. Based on profitability this year, it seems that the Psil strategy has paid off.
Before considering Stkd Bitcoin & Gold ETF, you will want to hear it.
Marketbeat monitors the highest and most effective analysts with the most effective Wall Street analysts and promotions that they recommend to their customers daily. Marketbeat has identified five shares that leading analysts quietly whisper to their clients to buy now before the wider market wins … And the Stkd Bitcoin & Gold ETF was not on the list.
While the Stkd Bitcoin & Gold ETF currently has a rating of “keep” among analysts, analysts with the highest rating believe that these five promotions are better buying.
View five shares here
Enter your email address, and we will send you the MarketBeat leadership for 5G investments and which 5G shares show the greatest promise.
Get this free report